CLASS II ONGOING Device recall · Reported 16 Jul 2025 · FDA Enforcement Report

VersaCross Transseptal Sheath Kit recalled by Boston Scientific

Boston Scientific is recalling VersaCross Transseptal Sheath Kit (VXS) Product Description/IDs VXS0201 VXS/45DEG/D0, distributed nationwide in the US. The recall was initiated on 10 Jun 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesVXS0201 UDI-DI 00685447020301 Lot 35800622; VXS2112 UDI-DI 00685447019251 Lot 35892045
Quantity recalled14,724

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2105-2025
FDA event ID
97036
Recalling firm
Boston Scientific, Saint Paul, MN
Classification
Class II
Status
Ongoing
Recall initiated
10 Jun 2025
FDA classified
10 Jul 2025
Reported
16 Jul 2025
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Sterility

Timeline

10 Jun 2025Recall initiated by company
10 Jul 2025Classified by FDA+30 days
16 Jul 2025Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

VersaCross Transseptal Sheath Kit (VXS) Product Description/IDs VXS0201 VXS 63CM/45DEG/D0 SHEATH VXS2112 VERSACROSS SHEATH (63CM 45DEG D0)-J Used for the percutaneous introduction of various types of cardiovascular catheters and guidewires to all heart chambers, including the left atrium via transseptal perforation / puncture.

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.

Nationwide

Questions about this recall

Why was it recalled?

Potential for hole in the Tyvek layer of the sterile barrier pouch, which may compromise device sterility. Issue could potentially lead to systemic infection and sepsis in worst case scenario. Potential punctures may go undetected in clinical settings due to small size and variable location.

Which lots are affected?

VXS0201 UDI-DI 00685447020301 Lot 35800622; VXS2112 UDI-DI 00685447019251 Lot 35892045

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Canada, Hong Kong, and Japan.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 97036

This product is part of a recall event; the main page for the event is Torflex Transseptal Guiding Sheath Kit recalled by Boston Scientific.

More recalls from Boston Scientific

All 626

Other Heart & Vascular Devices recalls

All 6,199